[Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
D000328:Adult; D000368:Aged; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004074:Digitoxin / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D007799:Lanatosides / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013328:Strophanthins / Q000627:therapeutic use; D013607:Tablets
D002301:Cardiac Glycosides; D007799:Lanatosides; D013328:Strophanthins; D013607:Tablets; D004074:Digitoxin
Klinische Untersuchungen mit dem neuen Herzglykosid Proscillaridin A (Sandoscill)